未登录

M

Makoto Tsujita

Japanese Red Cross Nagoya Daini Hospital

H指数:18

被引数:1,183

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Urinary Basigin/CD147 is a useful marker of acute T cell-mediated rejection in kidney transplant recipients

IF3

2025-03-240

OAAI

Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis

AMERICAN JOURNAL OF NEPHROLOGY

IF3.2

2024-02-024

PRE

Coexistence of low muscle mass and osteoporosis as a predictor of fragility fractures in long-term kidney transplant recipients

AMERICAN JOURNAL OF NEPHROLOGY

IF3.2

2023-09-122

PRE

Non-A Blood Type Is a Risk Factor for Poor Cardio-Cerebrovascular Outcomes in Patients Undergoing Dialysis

IF3.9

2023-02-160

OAAI

Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis

IF3

2023-01-2722

OAAI

CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors

IF3

2022-05-112

OAAI

Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2021-11-0812

OAAI

The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2021-09-017

OAAI

Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2021-05-0134

OAAI

Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States

美国新型冠状病毒肺炎危重症实体器官移植患者的预后

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2020-11-0187

OAAI

Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors

KIDNEY INTERNATIONAL REPORTS

IF5.7

2020-01-0113

OAAI

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study

SCIENTIFIC REPORTS

IF3.9

2019-10-1027

OAAI

Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation

在ABO血型不相容的肾移植中，针对hla-dr的从头供体特异性抗体的发生率较低

HUMAN IMMUNOLOGY

IF2.2

2019-03-015

PREAI

Total Parathyroidectomy with Autograft in Persistent Hyperparathyroidism After Renal Transplantation

TRANSPLANTATION

IF5

2018-07-010

PREAI

Marginal Factors do not Affect the Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation

TRANSPLANTATION

IF5

2018-07-010

PREAI

Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejection

HUMAN IMMUNOLOGY

IF2.2

2018-06-014

PREAI

De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury

TRANSPLANTATION

IF5

2016-10-0163

PREAI

5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessment

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2016-10-0113

PREAI

Association of Dialysis Duration with Outcomes after Transplantation in a Japanese Cohort

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2016-03-0135

OA

Elevated Fibloblast Growth Factor 23 Levels at 6 Months Predict Early Deterioration of Post-Transplant Kidney Function

TRANSPLANTATION

IF5

2014-07-010

PREAI